Randomization and treatment protocol
ARDS
ARDS
Patients were randomized 2:1 to receive either the investigational product invimestrocel plus standard treatment (invimestrocel group) or standard treatment (standard group) consistent with the clinical practice guidelines of the Japanese Respiratory Society for the management of ARDS [Patients in the invimestrocel group received standard treatment plus a single intravenous (IV) infusion of 9.0 × 10